|1.||Deng, Yong: 3 articles (11/2015 - 02/2015)|
|2.||Li, Yan: 3 articles (11/2015 - 02/2015)|
|3.||Qiang, Xiaoming: 2 articles (04/2015 - 02/2015)|
|4.||Liu, Qiang: 2 articles (04/2015 - 02/2015)|
|5.||Sang, Zhipei: 2 articles (04/2015 - 02/2015)|
|6.||Tan, Zhenghuai: 2 articles (04/2015 - 02/2015)|
|7.||Tang, Yuping: 2 articles (03/2014 - 01/2012)|
|8.||Tang, Hao: 2 articles (03/2014 - 01/2012)|
|9.||Shi, Qianping: 2 articles (03/2014 - 01/2012)|
|10.||Wu, Bei: 1 article (11/2015)|
|2.||Brain Ischemia (Cerebral Ischemia)
01/01/2012 - "Synthesis and protective effect of scutellarein on focal cerebral ischemia/reperfusion in rats."
03/01/2014 - "Our studies indicated that scutellarin and scutellarein could improve neuronal injury, and scutellarein had better protective effect than scutellarin in rat cerebral ischemia."
03/01/2014 - "Neuroprotective effects of scutellarin and scutellarein on repeatedly cerebral ischemia-reperfusion in rats."
01/01/2012 - "The results showed that scutellarein had better protective effect on focal cerebral ischemia/reperfusion than scutellarin, which laid the foundation for further research and development of scutellarein as a promising candidate for ischemic cerebro-vascular disease."
01/01/2012 - "Neurological deficit score and cerebral infarction volume with the administration of scutellarein were then used to compare its neuroprotective effects on focal cerebral ischemia/reperfusion in rats induced by middle cerebral artery occlusion (MCAO) with those of scutellarin. "
09/01/2010 - "To investigate the absorption and transepithelial transport characteristics of scutellarin and scutellarein in the human colonic adenocarcinoma cell (Caco-2) monolayer model. "
10/29/2009 - "In the present study, the metabolism of the flavonoids chrysin, baicalein, scutellarein, sinensetin and genkwanin by recombinant CYP1A1, CYP1B1 and CYP1A2 enzymes, as well as their antiproliferative activity in MDA-MB-468 human breast adenocarcinoma and MCF-10A normal breast cell lines, were investigated. "
|4.||Lung Neoplasms (Lung Cancer)
08/31/2014 - "In this study, scutellarein, a flavonoid compound, was screened for proliferation inhibition at different concentrations (0, 5, 25 and 50 μM) at 24 h or 48 h in human lung cancer cell line A549. "
08/31/2014 - "The experimental results showed that scutellarein could inhibit proliferation of the human lung cancer cell line A549 through ERK and NFκB mediated by the EGFR pathway. "
08/31/2014 - "Inhibitory effects of scutellarein on proliferation of human lung cancer A549 cells through ERK and NFκB mediated by the EGFR pathway."
03/01/2014 - "This study investigated whether the neural injury by ischemia/reperfusion would be influenced by different doses of scutellarin and scutellarein. "
03/01/2014 - "Male Wistar rats were orally administered with scutellarin and scutellarein at the doses of 0.09, 0.17, 0.35, 0.70, 1.40 mmol/kg, respectively; then after six consecutive days, they were subjected to global ischemia by occlusion of the bilateral common carotid arteries (BCCAO). "
|7.||Cytochrome P-450 CYP1A2 (CYP1A2)
|8.||Cytochrome P-450 CYP1A1 (CYP1A1)